Sort
50,496 grants matching “lung cancer”
Assessment of a Digitally Controlled Aerosolized Nicotine Replacement Therapy
$1,118,284James M Davis · Predictably Human, Inc. · R42 · FY2025 · DA
All-Human Microphysical Model of Metastasis Therapy
$1,118,169Linda G. Griffith · Massachusetts Institute Of Technology · UH2 · FY2012 · TR
Molecular Dynamics Simulations Of Biological Macromolecules
$1,117,834Bernard R Brooks · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
Interacting Signaling Pathways that Initiate Squamous Cell Carcinogenesis
$1,117,299Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer
$1,116,803Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Tumor Microenvironment in Cancer Progression
$1,116,420Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
PRINT: Nanoparticles: "Calibration Quality" Nano-tools for Studying the Effect of
$1,115,780Joseph M Desimone · Univ Of North Carolina Chapel Hill · U54 · FY2011 · CA
TNF Signaling and Cell Death
$1,115,519Zheng-Gang Liu · Division Of Clinical Sciences - Nci · ZIA · FY2012 · CA
Point-of-Care Microfluidics in Lung Cancer
$1,115,405Mehmet Toner · Massachusetts General Hospital · R01 · FY2008 · EB
Patient Oriented Research in Viral Malignancies and HIV-associated Cancers
$1,114,919Thomas Uldrick · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Epigenomics of T cells and innate immune cells in human asthma
$1,114,630Anjana Rao · La Jolla Institute For Immunology · R01 · FY2012 · HL
PROSTATE LUNG COLORECTAL OVARIAN (PLCO) ETIOLOGIC AND EARLY MARKER STUDIES (EEMS)
$1,114,478Thomas Riley · Information Management Services, Inc. · N02 · FY2022 · CA
Point-of-Care Microfluidics in Lung Cancer
$1,114,356Mehmet Toner · Massachusetts General Hospital · R01 · FY2009 · EB
Stroger Hospital of Cook County (SHCC) MU-NCORP Renewal
$1,114,283Thomas Lad · Hektoen Institute For Medical Research · UG1 · FY2021 · CA
Clinical Trials of Immunotherapies for Childhood Cancer
$1,113,902Crystal Mackall · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Molecular Dynamics Simulations Of Biological Macromolecules
$1,113,655Bernard R Brooks · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
The Boston Lung Cancer Survival Cohort
$1,113,227David C Christiani · Harvard University D/B/A Harvard School Of Public Health · U01 · FY2024 · CA
Telomere Diseases
$1,112,403Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
Integrated analyses of genetics, epigenetics, and gene expression
$1,112,396Maxwell Lee · Division Of Basic Sciences - Nci · ZIH · FY2023 · CA
The Houston Center for Acquired Resistance Research (H-CARR)
$1,112,099Jeffrey Nicholas Myers · University Of Tx Md Anderson Can Ctr · U54 · FY2024 · CA
Southern Environmental Health Study
$1,110,930Wei Zheng · Vanderbilt University Medical Center · UG3 · FY2022 · CA
Genetic Epidemiology of Cancer
$1,110,655Joan E. Bailey-Wilson · National Human Genome Research Institute · ZIA · FY2021 · HG
Transdisciplinary Research in Cancer of the Lung- Discovery of Novel Variants
$1,110,305Christopher I. Amos · Dartmouth College · U19 · FY2013 · CA
Assessing the integration of tobacco cessation treatment into lung cancer screening
$1,109,934Elyse R Park · Massachusetts General Hospital · R01 · FY2022 · CA
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
$1,109,810Harold John Burstein · Dana-Farber Cancer Inst · UG1 · FY2021 · CA